Retinopathy in subjects with impaired fasting glucose: the NANSY-Eye baseline report
International journal of physiology, pathophysiology and pharmacology , 10 (3), 132138
Senescent Chondrocyte Removal & Chondrogenic Potential Restoration (PMC, 2021) FOXO4-DRI Removes Replication-Stress Senescent Chondrocytes in ACI Research Model A study published in PMC investigated FOXO4-DRI in the context of autologous chondrocyte implantation (ACI) a procedure in which in vitro chondrocyte expansion generates a senescent cell burden that adversely affects cartilage formation quality and quantity
It is not a medicine, drug, cosmetic, or dietary supplement, and it has not been approved for human or veterinary use
Its enhanced chemical stability, particularly for oral research applications, is its defining characteristic and key advantage over the traditional acetate salt